Our top pick for
Cantel Medical Corp is a medical instruments & supplies business based in the US. Cantel Medical shares (CMD) are listed on the NYSE and all prices are listed in US Dollars. Cantel Medical employs 3,669 staff and has a trailing 12-month revenue of around 0.00.
|52-week range||$29.34 - $89.76|
|50-day moving average||$82.63|
|200-day moving average||$71.76|
|Wall St. target price||$62.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$1.09|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Cantel Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cantel Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cantel Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 81x. In other words, Cantel Medical shares trade at around 81x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Cantel Medical's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.4104. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cantel Medical's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cantel Medical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $202.6 million.
The EBITDA is a measure of a Cantel Medical's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$1.1 billion|
|Operating margin TTM||12.6%|
|Gross profit TTM||$462.6 million|
|Return on assets TTM||4.24%|
|Return on equity TTM||6.19%|
|Market capitalisation||$3.7 billion|
TTM: trailing 12 months
There are currently 2.4 million Cantel Medical shares held short by investors – that's known as Cantel Medical's "short interest". This figure is 20.4% up from 2.0 million last month.
There are a few different ways that this level of interest in shorting Cantel Medical shares can be evaluated.
Cantel Medical's "short interest ratio" (SIR) is the quantity of Cantel Medical shares currently shorted divided by the average quantity of Cantel Medical shares traded daily (recently around 468913.68015414). Cantel Medical's SIR currently stands at 5.19. In other words for every 100,000 Cantel Medical shares traded daily on the market, roughly 5190 shares are currently held short.
However Cantel Medical's short interest can also be evaluated against the total number of Cantel Medical shares, or, against the total number of tradable Cantel Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cantel Medical's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Cantel Medical shares in existence, roughly 60 shares are currently held short) or 0.0737% of the tradable shares (for every 100,000 tradable Cantel Medical shares, roughly 74 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Cantel Medical.
Find out more about how you can short Cantel Medical stock.
We're not expecting Cantel Medical to pay a dividend over the next 12 months.
Cantel Medical's shares were split on a 3:2 basis on 14 July 2013. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Cantel Medical shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Cantel Medical shares which in turn could have impacted Cantel Medical's share price.
Over the last 12 months, Cantel Medical's shares have ranged in value from as little as $29.34 up to $89.76. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cantel Medical's is 1.5416. This would suggest that Cantel Medical's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants.
Everything we know about the TC Bancshares IPO, plus information on how to buy in.
Everything we know about the Soulgate IPO, plus information on how to buy in.
Everything we know about the Alzamend Neuro IPO, plus information on how to buy in.
Everything we know about the Singular Genomics Systems IPO, plus information on how to buy in.
Everything we know about the Golden Sun Education Group Limited IPO, plus information on how to buy in.
Everything we know about the Phillips Edison & Company IPO, plus information on how to buy in.
Everything we know about the FIGS IPO, plus information on how to buy in.
Everything we know about the DLocal Limited IPO, plus information on how to buy in.
Everything we know about the Torchy’s Tacos IPO, plus information on how to buy in.
Everything we know about the Dutch Bros Coffee IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.